Neurocrine Biosciences
NBIX
#1464
Rank
A$21.85 B
Marketcap
A$215.04
Share price
-1.19%
Change (1 day)
0.78%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company